27 related articles for article (PubMed ID: 38465959)
1. The clinical value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in postoperative patients with gastrointestinal mucinous adenocarcinoma.
Yang ZY; Hu SL; Shi W; Zhu BL; Xu JY; Zhang YJ
Nucl Med Commun; 2011 Nov; 32(11):1018-25. PubMed ID: 21956489
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
Whiteford MH; Whiteford HM; Yee LF; Ogunbiyi OA; Dehdashti F; Siegel BA; Birnbaum EH; Fleshman JW; Kodner IJ; Read TE
Dis Colon Rectum; 2000 Jun; 43(6):759-67; discussion 767-70. PubMed ID: 10859074
[TBL] [Abstract][Full Text] [Related]
3. A role of 18F-fluorodeoxyglucose positron emission/computed tomography in a strategy for abdominal wall metastasis of colorectal mucinous adenocarcinoma developed after laparoscopic surgery.
Funahashi K; Ushigome M; Kaneko H
World J Surg Oncol; 2011 Feb; 9():28. PubMed ID: 21352607
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T
Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
[TBL] [Abstract][Full Text] [Related]
5. Use of semiquantitative analysis in local recurrence of colorectal carcinoma with
Gedik GK; Yilmaz F
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):366-372. PubMed ID: 30193775
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Recurrence of Colorectal Mucinous Adenocarcinoma and Sarcoidosis on 18 F-FDG PET/CT.
Habouzit V; Maoui K; Prevot N; Forest F; Grange R
Clin Nucl Med; 2024 May; 49(5):475-477. PubMed ID: 38465959
[TBL] [Abstract][Full Text] [Related]
7. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
Laurens ST; Oyen WJ
PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671
[TBL] [Abstract][Full Text] [Related]
8. PET and PET-CT for evaluation of colorectal carcinoma.
Delbeke D; Martin WH
Semin Nucl Med; 2004 Jul; 34(3):209-23. PubMed ID: 15202102
[TBL] [Abstract][Full Text] [Related]
9. FDG PET/CT in colorectal cancer.
Rodríguez-Fraile M; Cózar-Santiago MP; Sabaté-Llobera A; Caresia-Aróztegui AP; Delgado Bolton RC; Orcajo-Rincon J; de Arcocha-Torres M; García-Velloso MJ; García-Talavera P
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):57-66. PubMed ID: 31776063
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography in colorectal cancer.
Flamen P
Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):237-51. PubMed ID: 11969236
[TBL] [Abstract][Full Text] [Related]
11. FDG-PET/CT Assessment of Pulmonary Sarcoidosis: A Guide for Internists.
Tana M; di Carlo S; Romano M; Alessandri M; Schiavone C; Montagnani A
Curr Med Imaging Rev; 2019; 15(1):21-25. PubMed ID: 31964323
[TBL] [Abstract][Full Text] [Related]
12. [Importance of FDG-PET/computed tomography in colorectal cancer].
Kleiner S; Weber W
Radiologe; 2019 Sep; 59(9):812-819. PubMed ID: 31428810
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
